🔗 Share this article

An underground market for unlicensed weight-loss drugs is being driven by TikTok fitness influencers and sellers on communication apps, according to recent findings.

Experimental Treatment Acquiring Traction Via Social Media

The experimental drug, which remains in research studies, is being promoted by social media influencers for its supposed weight-reducing properties. Viewers are encouraged to contact these profiles directly for source information, while also obtaining promotional offers.

Thriving Trade on Messaging Platforms

Separately, a robust market exists on messaging services, where groups with numerous of members share comparison photos, injection guides and claims of rapid British shipping. Vendors promote the substance there before redirecting buyers to WhatsApp for transactions.

Understanding The Experimental Drug

This medication is an investigational injectable created by US drugmaker Eli Lilly. The drug affects three intestinal hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies indicate it could assist patients reduce up to a quarter of their total weight. Nicknamed the “triple G”, the drug is being promoted online as the successor to Ozempic.

Medical Experts Express Worries

However, physicians and pharmacists have warned that the distribution of what remains an unlicensed drug in the United Kingdom is worrisome and could lead to users administering products of uncertain source.

Several professionals said the popularity for the experimental drug could be linked to the increasing price of licensed weight loss treatments such as Mounjaro.

Regulatory Status and Enforcement

Marketing retatrutide on TikTok or messaging apps is illegal in the United Kingdom, as it is an unapproved drug that must not be marketed or distributed for human use under the Human Medicines Regulations 2012.

Some influencers try to sidestep the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but promotion and distribution can still breach medicines, marketing, and consumer regulations, potentially leading to penalties, legal action or imprisonment.

Platform Reaction and Material Removal

According to the social media company, the platform has taken down problematic content and banned associated hashtags and search suggestions. The company said it was committed to keeping the platform safe and allocating resources in strengthening enforcement strategies.

Digital Marketplace Activities

Research also found communities with up to 9,000 participants selling the experimental drug using the platform's integrated discovery tool, which operates like a online catalog. Typing “retatrutide” instantly brings up groups with thousands of members, populated with photos of weight loss, positive testimonials and detailed guides for mixing or administering at home.

Within minutes of entering one group, a vendor posted WhatsApp details, where most purchases take place. The vendor provided an instruction manual and guaranteed shipping within 48 hours. When questioned whether the product was authentic, one seller said: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. Not one inquired about weight, medical conditions or past usage.

Product Information and Pricing

Inside these communities, messages display dark colored parcels with postal service stickers, stating to include new batches. One communication read: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, prepared at home with purified liquid, or pre-filled injectors usually sold at £160 for 20 milligrams. When questioned how long a pen should last, sellers give contradictory answers ranging from a few weeks to “depends on your body”.

Platform Moderation and Security Actions

A representative for Telegram said it regularly moderated harmful material on its service including material that promoted the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Warnings

“Individuals are injecting substances they can’t verify. Although the science behind this drug is sound, these online products may not include what they advertise,” said Jason Murphy, the head of pharmacy at a pharmacy service.

A medical professional of an online medical service connected the surge in demand to current cost increases for approved weight-loss medications such as Mounjaro. “With costs increasing, patients are using social media. But fake injections are highly risky. You cannot know what’s inside or whether the environment they were produced in was clean,” she said.

Her team has already seen individuals injured by personal administration from unconfirmed suppliers. “We recognize the frustration, but buying from messaging apps or communication platforms is gambling with your well-being,” said Wyllie. “These substances could be contaminated or incorrectly dosed.”

Producer Position

A spokesperson from Eli Lilly said retatrutide was in third stage research studies and had not been reviewed or authorized by any government authority globally. “Consequently at this time no one can sell [it] for human use,” they explained, adding that any product “misleadingly claiming itself as a Lilly experimental substance not yet authorized … may expose patients to potentially significant health risks”.